Ralph Harmon Llc | |
112 W Washington St Ste F Marquette MI 49855-4367 | |
(906) 250-2382 | |
(906) 627-6337 |
Full Name | Ralph Harmon Llc |
---|---|
Speciality | Social Worker |
Location | 112 W Washington St Ste F, Marquette, Michigan |
Authorized Official Name and Position | Marybeth Houpt (CREDENTIALING) |
Authorized Official Contact | 5176769788 |
Accepts Medicare Insurance | Yes. This clinic participates in medicare program and accept medicare insurance. |
Mailing Address | Practice Location Address |
---|---|
Ralph Harmon Llc Po Box 10 Mason MI 48854-0010 Ph: () - | Ralph Harmon Llc 112 W Washington St Ste F Marquette MI 49855-4367 Ph: (906) 250-2382 |
NPI Number | 1245800184 |
---|---|
Provider Enumeration Date | 07/01/2021 |
Last Update Date | 07/15/2021 |
Certification Date | 07/15/2021 |
Medicare PECOS PAC ID | 4789086398 |
---|---|
Medicare Enrollment ID | O20210706000512 |
News Archive
A study by researchers at Marshall University Joan C. Edwards School of Medicine has found that blocking the blood supply of small cell lung cancer tumors may help reduce their growth and delay the regrowth process after treatment. Small cell lung cancer is considered the most lethal of all lung cancers.
A group of researchers from Stanford in collaboration with other universities have found that in humans a low level of acetyl-L-carnitine or L-acetyle carnitine in blood could be a predictor of the duration and severity of depression.
Recently, the accuracy of current methods of pain assessment in babies have been called into question. New research from London-area hospitals and the University of Oxford measures brain activity in infants to better understand their pain response.
Research by Yale scientists shows that males and females have essentially unisex brains - at least in flies - according to a recent report in Cell designed to identify factors that are responsible for sex differences in behavior.
BioNumerik Pharmaceuticals, Inc. today announced the treatment of the first patients in a global multi-center Phase III clinical trial of Tavocept (BNP7787) in patients with primary adenocarcinoma of the lung, the most common type of lung cancer. In previous studies, Tavocept demonstrated the potential to substantially increase overall and one year patient survival while concurrently preventing and reducing the incidence and severity of common chemotherapy side-effects as compared to other currently available treatments for advanced lung cancer.
› Verified 3 days ago
Identifier | Type | State | Issuer |
---|---|---|---|
1245800184 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
104100000X | Social Worker | (* (Not Available)) | Primary |
Provider Name | Ralph L Harmon |
---|---|
Provider Type | Practitioner - Clinical Social Worker |
Provider Identifiers | NPI Number: 1164716361 PECOS PAC ID: 6002088283 Enrollment ID: I20111012000282 |
News Archive
A study by researchers at Marshall University Joan C. Edwards School of Medicine has found that blocking the blood supply of small cell lung cancer tumors may help reduce their growth and delay the regrowth process after treatment. Small cell lung cancer is considered the most lethal of all lung cancers.
A group of researchers from Stanford in collaboration with other universities have found that in humans a low level of acetyl-L-carnitine or L-acetyle carnitine in blood could be a predictor of the duration and severity of depression.
Recently, the accuracy of current methods of pain assessment in babies have been called into question. New research from London-area hospitals and the University of Oxford measures brain activity in infants to better understand their pain response.
Research by Yale scientists shows that males and females have essentially unisex brains - at least in flies - according to a recent report in Cell designed to identify factors that are responsible for sex differences in behavior.
BioNumerik Pharmaceuticals, Inc. today announced the treatment of the first patients in a global multi-center Phase III clinical trial of Tavocept (BNP7787) in patients with primary adenocarcinoma of the lung, the most common type of lung cancer. In previous studies, Tavocept demonstrated the potential to substantially increase overall and one year patient survival while concurrently preventing and reducing the incidence and severity of common chemotherapy side-effects as compared to other currently available treatments for advanced lung cancer.
› Verified 3 days ago
News Archive
A study by researchers at Marshall University Joan C. Edwards School of Medicine has found that blocking the blood supply of small cell lung cancer tumors may help reduce their growth and delay the regrowth process after treatment. Small cell lung cancer is considered the most lethal of all lung cancers.
A group of researchers from Stanford in collaboration with other universities have found that in humans a low level of acetyl-L-carnitine or L-acetyle carnitine in blood could be a predictor of the duration and severity of depression.
Recently, the accuracy of current methods of pain assessment in babies have been called into question. New research from London-area hospitals and the University of Oxford measures brain activity in infants to better understand their pain response.
Research by Yale scientists shows that males and females have essentially unisex brains - at least in flies - according to a recent report in Cell designed to identify factors that are responsible for sex differences in behavior.
BioNumerik Pharmaceuticals, Inc. today announced the treatment of the first patients in a global multi-center Phase III clinical trial of Tavocept (BNP7787) in patients with primary adenocarcinoma of the lung, the most common type of lung cancer. In previous studies, Tavocept demonstrated the potential to substantially increase overall and one year patient survival while concurrently preventing and reducing the incidence and severity of common chemotherapy side-effects as compared to other currently available treatments for advanced lung cancer.
› Verified 3 days ago
Margaret A. Macdevitt Ph.d, Pc Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 123 E Arch St, Marquette, MI 49855 Phone: 906-226-9584 Fax: 906-228-8057 | |
Small Pine Tree Counseling Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 104 E Washington St, Marquette, MI 49855 Phone: 906-228-3092 Fax: 906-273-1434 | |
Access Psychological Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 106 W Washington St, Marquette, MI 49855 Phone: 906-228-8881 | |
Quickmd Medical Group Pa Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 1805 Harbour View Dr, Marquette, MI 49855 Phone: 888-878-4256 | |
Teaching Family Homes Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 1000 Silver Creek Rd, Marquette, MI 49855 Phone: 906-249-5437 Fax: 906-249-5438 | |
Superior Rehab Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 1310 S Front St, Suite C, Marquette, MI 49855 Phone: 906-273-1517 Fax: 906-273-1519 | |
Monica L. Nordeen, Lmsw Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 112 W Washington St Ste G, Marquette, MI 49855 Phone: 906-250-0933 |